No headlines found.
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
ACCESSWIRE (Thu, 11-Apr 9:10 AM ET)
Edesa Biotech to Participate in Upcoming Investor Conferences
ACCESSWIRE (Tue, 2-Apr 9:11 AM ET)
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
ACCESSWIRE (Thu, 21-Mar 4:30 PM ET)
Edesa Biotech to Participate in Barclays Global Healthcare Conference
ACCESSWIRE (Thu, 7-Mar 8:47 AM ET)
Edesa Biotech to Participate in Upcoming Dermatology Meetings
ACCESSWIRE (Mon, 4-Mar 4:31 PM ET)
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
ACCESSWIRE (Fri, 9-Feb 4:17 PM ET)
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Edesa Biotech - Common Shares trades on the NASDAQ stock market under the symbol EDSA.
As of April 19, 2024, EDSA stock price climbed to $4.45 with 2,428 million shares trading.
EDSA has a beta of 1.10, meaning it tends to be more sensitive to market movements. EDSA has a correlation of 0.04 to the broad based SPY ETF.
EDSA has a market cap of $14.31 million. This is considered a Sub-Micro Cap stock.
Last quarter Edesa Biotech - Common Shares reported $0 in Revenue and -$.54 earnings per share. This met revenue expectation and exceeded earnings estimates by $.67.
In the last 3 years, EDSA stock traded as high as $84.00 and as low as $2.46.
The top ETF exchange traded funds that EDSA belongs to (by Net Assets): VXF.
EDSA has underperformed the market in the last year with a price return of -41.1% while the SPY ETF gained +21.2%. EDSA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.1% and -4.8%, respectively, while the SPY returned +3.0% and -4.5%, respectively.
EDSA support price is $4.08 and resistance is $4.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EDSA stock will trade within this expected range on the day.